FRANKFURT, Aug 31 (Reuters) - The following are some of the factors that may move German stocks on Thursday:
The group said it had submitted a Biologics License Application with the U.S. Food and Drug Administration (FDA) for BAY94-9027 for the treatment of Hemophilia A.
German court ruling expected in legal test case brought against Volkswagen by consumer rights champion MyRight for selling cars with software banned under EU regulation.
Retailer Metro and consumer electronics group Ceconomy, which split and listed separately last month, both reported sales recovered in their fiscal third quarter on Thursday, helped by fast-growing online and delivery services.
The group said it expected a positive business development ahead as it reported broadly flat second-quarter pretax profit.
The steelmaker has filed a protest against duties imposed in the United States and is in touch with the German government and the European Commission to push for a complaint with the World Trade Organization, Chief Executive Heinz Joerg Fuhrmann told German daily Die Welt.
The group reported its nine-month sales jumped 48 percent to 14.9 billion euros, with 8 percent organic growth.
Q2 report due. The group reported preliminary results and raised its guidance on Aug. 24.
German airline Germania has complained to the European Commission that rival Air Berlin is receiving unwarranted state aid, Germania’s Chief Executive Karsten Balke told Germany’s Frankfurter Allgemeine Zeitung.
H1 results due.
STADA - dividend 0.72 eur/shr
BIOTEST - dividend 0.05 eur/ordinary shr, 0.07 eur/preference share
German July retail sales due at 0600 GMT. Seen -0.4 pct m/m, +3.5 pct y/y.
German August jobless figures due at 0800 GMT. Seen -6,000 seasonally adjusted, unemployment rate seen unchanged at 5.7 pct.
REUTERS TOP NEWS ($1 = 0.8365 euros) (Reporting by Edward Taylor and Maria Sheahan)